drugset / Trial / NCT00323310
Safety and Efficacy of MultiHance in Pediatric Patients
Non-randomizedSingle-groupOpen-labelDiagnostic
Summary
The purpose of this study was to assess the safety and enhancing properties of the magnetic resonance imaging (MRI) contrast agent MultiHance in children aged 2 to 17 years having central nervous system (CNS) disorders.
Timeline
- Start
- 2006-04
- Primary completion
- 2008-09
- Completion
- 2008-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gadobenate dimeglumine | Diagnostic / imaging agent | 0.1 mmol | Intravenous |